×

What are you searching for?




Healthcare

4 Min read

CureVac to begin clinical trials for second-generation COVID-19 vaccine

Published On 19 Nov 2021 01:09 PM


SHARE THIS ARTICLE  


German biotechnology company CureVac said on November 18 that clinical trials for its second-generation COVID-19 vaccine will begin in the next few months.

Highlights

  • CureVac to begin clinical trials of its second-generation COVID-19 vaccine
  • This vaccine uses improved mRNA vaccine technology

Earlier, the company published data which showed that the next-generation shot C....


Tags : Development, Efficacy, CureVac, CVnCoV, mRNA Vaccine,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)